CATALYST PHARMACEUTICAL PARTNERS, INC.
Coral Gables, FL US
|CATALYST PHARMACEUTICAL PARTNERS, INC. Patent applications|
|Patent application number||Title||Published|
|20130041028||METHODS OF USING (1S,3S)-3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANOIC ACID - (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 or its pharmaceutically acceptable salts can be used to treat addiction and neurological disorders such as epilepsy without side effects such as visual field defects caused by vigabatrin (Sabril).||02-14-2013|